精神在线网 > 专题浏览 > 肿瘤、疼痛与精神疾病研究英文文献
FNISI Export Format
VR1.0
PT J
AU Aitini, E
Sempreboni, A
Aleotti, P
Zamagni, D
Cavazzini, G
Barbieri, R
Cengarle, R
Rabbi, C
Pari, F
Vivorio, B
AF Aitini, Enrico
Sempreboni, Alessia
Aleotti, Paola
Zamagni, Donatella
Cavazzini, Giovanna
Barbieri, Roberto
Cengarle, Rita
Rabbi, Carla
Pari, Franca
Vivorio, Beatrice
TI Anxiety levels in cancer patients and "life sound" experience
SO TUMORI
AB Aims and background: For the hospitalized cancer patient, time takes on a rhythm which is very different from the external reality. Based on the idea that time represents a fundamental dimension of human existence and is connected to future plans, time spent waiting and memories, we carried out this experience entitled "Life Sound" project. The objectives of the project were to experiment different and unusual ways of spending time in hospital in order to improve the quality of life of the hospitalized cancer patient, to help the patient adapt to the hospital environment, to encourage awareness of self and to give a different meaning to time spent in the hospital. In particular, we evaluated the reduction in the levels of anxiety, in psychological suffering and the improvement in communication.
Methods: We met with patients, family members, friends, volunteers and department personnel (doctors, psychologists, nurses) in a room in the Oncology and Hematology Department set aside specifically for recreation activities such as having a cup of tea while listening to music, talking, joking, listening to people's memories and celebrating birthdays, anniversaries and other special days. The study, which involved 109 patients, was carried out through the use of the questionnaire STAI-Y distributed before and after the event.
Results: The results showed a statistically significant difference in anxiety levels 2 hrs before participation (mean = 38.33) and 2 hrs after participation (mean = 34.77) in the program. This variation was also assessed based on gender, age, cancer stage, time since diagnosis and performance status but did not result in any statistically significant difference.
Conclusions: The "Life Sound" project encourages the emergence of positive feelings, of a renewed willingness to invest in personal and caring relationships, which are connected to the patient's ability to face this illness, and the opening of new channels of communication with family members and hospital staff.
SN 0300-8916
PD JAN-FEB
PY 2007
VL 93
IS 1
BP 75
EP 77
UT ISI:000247166900013
ER

PT J
AU Badger, T
Segrin, C
Dorros, SM
Meek, P
Lopez, AM
AF Badger, Terry
Segrin, Chris
Dorros, Sybilla M.
Meek, Paula
Lopez, Ana Maria
TI Depression and anxiety in women with breast cancer and their partners
SO NURSING RESEARCH
AB Background: Psychosocial interventions can improve psychological quality of life (symptoms of depression and anxiety) of both women with breast cancer and their partners, but are not offered routinely to women and their partners.
Objective: To test the. hypotheses that telephone-delivered psychosocial interventions decrease depression and anxiety in women with breast cancer and their partners.
Methods: The design of the study was a three-wave repeated measures with a between-subjects factor (treatment group). Ninety-six women and their 96 partners were assigned randomly to participate in one of three different 6-week programs: (a) telephone interpersonal counseling (TIP-C); (b) self-managed exercise; or (c) attention control (AC).
Results: The mixed-model analysis of variance for symptoms of depression among women with breast cancer revealed women's depressive symptom scores decreased over time in all groups. For anxiety, women's symptoms of anxiety decreased in the TIP-C and exercise groups over time, but not in the AC group. A parallel set of analyses was conducted on partners' depression and anxiety data, Symptoms of depression and anxiety among the partners decreased substantially over the course of the investigation. Similar to the women, partners' symptoms of anxiety decreased significantly in the TIP-C and exercise groups, but not in the AC group.
Discussion: Findings from this study support that these telephone-delivered psychosocial interventions were effective for decreasing symptoms of depression and anxiety to improve psychological quality of life when compared to an AC group.
SN 0029-6562
PD JAN-FEB
PY 2007
VL 56
IS 1
BP 44
EP 53
UT ISI:000247102400006
ER

PT J
AU Dale, W
Hemmerich, J
Meltzer, D
AF Dale, William
Hemmerich, Joshua
Meltzer, David
TI Extending the validity of the Prostate Cancer (MAX-PC) Memorial Anxiety Scale for at the time of prostate biopsy in a racially-mixed population
SO PSYCHO-ONCOLOGY
AB The Memorial Anxiety Scale for Prostate Cancer (MAX-PC) has been validated for assessing men with prostate cancer for cancer-specific anxiety. It was originally validated in a predominantly white population. The MAX-PC Prostate Cancer Anxiety Subscale (MAX-PC-PCAS) may be relevant for measuring cancer-specific anxiety in undiagnosed men at risk for prostate cancer. We assess the validity of the MAX-PC-PCAS at the time of prostate biopsy (n = 178). Questions assessed socio-demographic information, health status, patient-estimated risk of cancer, the Hospital Anxiety and Depression Scale-Anxiety Subscale (HADS-A), and the MAX-PC-PCAS. The patients' most recent PSA was recorded. Cronbach's alpha, inter-item correlations, and Pearson correlations with both the HADS-A and clinical variables were compared with the original validation sample. Our sample was younger (63.1 vs 71.1 years), had a larger fraction of African-Americans (43 vs 10%), and had higher PSAs. Cronbach's alpha was equivalent (0.91 vs 0.90), median inter-item correlation was equivalent (0.63 vs 0.61), and Pearson correlation with HADS-A was higher (0.71 vs 0.57). Anxiety levels were not correlated with PSA levels, and there were minor differences in the validation findings by race. The validity of the MAX-PC-PCAS extends to men without cancer undergoing biopsy and to African-Americans. Copyright (c) 2006 John Wiley & Sons, Ltd.
SN 1057-9249
PD MAY
PY 2007
VL 16
IS 5
BP 493
EP 498
UT ISI:000246783300011
ER

PT J
AU Midtqaard, J
Rorth, M
Steller, R
Tveteras, A
Andersen, C
Quist, M
Moller, T
Adamsen, L
AF Midtqaard, J.
Rorth, M.
Steller, R.
Tveteras, A.
Andersen, C.
Quist, M.
Moller, T.
Adamsen, L.
TI Exercise during cytostatic treatment: correlates of cancer patients' self-reported anxiety and depression
SO EJC SUPPLEMENTS
SN 1359-6349
PD OCT
PY 2005
VL 3
IS 2
SU Suppl. S
BP 369
EP 369
UT ISI:000247564801434
ER

PT J
AU Iconomou, G
Koutras, AK
Assimakopoulos, K
Mega, V
Viha, A
Iconomou, AV
Kalofonos, HP
AF Iconomou, G.
Koutras, A. K.
Assimakopoulos, K.
Mega, V.
Viha, A.
Iconomou, A. V.
Kalofonos, H. P.
TI Anxiety, depression and quality of life in cancer patients treated with chemotherapy: a prospective examination
SO EJC SUPPLEMENTS
SN 1359-6349
PD OCT
PY 2005
VL 3
IS 2
SU Suppl. S
BP 380
EP 381
UT ISI:000247564801473
ER

PT J
AU Reineke, A
Sowder, E
Gevirtz, R
AF Reineke, Anke
Sowder, Erik
Gevirtz, Richard
TI Effects of an inter-active biofeedback game on anxiety and pain in children with cancer
SO BIOLOGICAL PSYCHOLOGY
SN 0301-0511
PD MAY
PY 2007
VL 75
IS 2
BP 213
EP 214
UT ISI:000246753200047
ER

PT J
AU Cousson-Gelie, F
Bruchon-Schweitzer, M
Dilhuydy, JM
Jutand, MA
AF Cousson-Gelie, Florence
Bruchon-Schweitzer, Marilou
Dilhuydy, Jean Marie
Jutand, Marthe-Aline
TI Do anxiety, body image, social support and coping strategies predict survival in breast cancer? A ten-year follow-up study
SO PSYCHOSOMATICS
AB A longitudinal study enrolled 75 women with primary breast cancer. Before the confirmation of diagnosis, authors measured trait-anxiety and body satisfaction. Three weeks after diagnosis, coping strategies and state-anxiety were evaluated. The number of days of survival was measured 10 years after diagnosis. In Cox proportional-hazards models adjusting for severity of disease and age, high social support and low state-anxiety predicted an increased risk of death from breast cancer. A significant increased risk of death in women with low scores on the Body Image Questionnaire appeared only in the univariate model.
SN 0033-3182
PD JUN
PY 2007
VL 48
IS 3
BP 211
EP 216
UT ISI:000246210400004
ER

PT J
AU Trumbo, CW
McComas, KA
Kannaovakun, P
AF Trumbo, Craig W.
McComas, Katherine A.
Kannaovakun, Prathana
TI Cancer anxiety and the perception of risk in alarmed communities
SO RISK ANALYSIS
AB Cancer is a significant public health topic and is frequently a factor in public reactions to environmental hazards. It may be reasonable to suggest that a unique form of health anxiety exists-one specific to cancer. In this article, we explore a measure of cancer anxiety that has applicability to risk perception in the specific context of communities that are alarmed over suspect cancer rates thought to be associated with environmental hazards. A literature search was used to identify survey questions previously used to measure cancer worry, fear, anxiety, etc. A list of 24 items was employed in a mail survey sent to 30 communities in which cancer rates were under investigation (part of a broader study). An analysis of the dataset of 1,111 responses yields two versions of a cancer anxiety scale: one an additive combination of 21 items (alpha= 0.77) and the other a two-factor model consisting of nine- and four-item subscales (alpha = 0.74 and 0.69). The resulting scales are evaluated for their ability to predict perception of risk from the environmental hazards in these cases. Controlling for age, sex, and cancer status, the scales explain between 2% and 10% of risk perception (full R-2 values ranging from 0.17 to 0.24). Given the range of concepts required to model risk perception, we conclude that this measure of cancer anxiety is sufficiently reliable and robust to be recommended for use in circumstances involving hazards associated with cancer. Other uses and further development of the measure are discussed.
SN 0272-4332
PD APR
PY 2007
VL 27
IS 2
BP 337
EP 350
UT ISI:000246625600007
ER

PT J
AU Tagay, VS
Senf, W
Schopper, N
Mewes, R
Bockisch, A
Gorges, R
AF Tagay, Von Sefik
Senf, Wolfgang
Schoepper, Nicole
Mewes, Ricarda
Bockisch, Andreas
Goerges, Rainer
TI Protective factors for anxiety and depression in thyroid cancer patients
SO ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE
AB Objectives: Depression and anxiety are the most common mental symptoms in patients with thyroid cancer (DTC) and have an important influence on the quality of life. The aim of the current study was to identify protective factors of depression and anxiety in DTC patients.
Methods: In a cross-sectional study 230 DTC patients were examined with Hospital Anxiety and Depression Scale (HADS-D), the Sense of Coherence Scale (SOC-13) and the Questionnaire of Social Support (F-SOZU).
Results: Depression correlated highly significantly with anxiety (r = .633, p = 0,001). Social support and sense of coherence correlated highly significantly negative with depression as well as with anxiety (both p <= 0,001). Although still significant, the correlation between age and anxiety was lower (r = -19; p <= 0,005). The TSH level as an indicator of hypothyreodism did not correlate with depression or with anxiety on a significant statistical level. Furthermore, variables such as education, religiosity and elapsed time interval since initial diagnosis were not correlated with depression and anxiety.
Discussion: Our results support the thesis that low social support and low sense of coherence enhance vulnerability to depressive and anxiety symptoms.
SN 1438-3608
PY 2007
VL 53
IS 1
BP 62
EP 74
UT ISI:000244928300007
ER

PT J
AU Sharp, DM
Walker, AA
Walker, MB
Walker, LG
AF Sharp, D. M.
Walker, A. A.
Walker, M. B.
Walker, L. G.
TI Are high levels of clinically significant anxiety and depression inevitable in the six months following the diagnosis of early breast cancer?
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD MAR
PY 2007
VL 16
IS 3
BP 272
EP 273
UT ISI:000244976700041
ER

PT J
AU Greer, J
Temel, J
Pirl, W
Lynch, T
AF Greer, J.
Temel, J.
Pirl, W.
Lynch, T.
TI Anxiety, quality of life and chemotherapy adherence among patients with advanced non-small cell lung cancer
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD MAR
PY 2007
VL 16
IS 3
SU Suppl. S
BP S13
EP S13
UT ISI:000245044900023
ER

PT J
AU Zhang, A
Cooper, G
AF Zhang, A.
Cooper, G.
TI Recognition of depression and anxiety among colorectal cancer patients
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD MAR
PY 2007
VL 16
IS 3
SU Suppl. S
BP S23
EP S24
UT ISI:000245044900042
ER

PT J
AU BrintzenhofeSzoc, KM
Levin, TT
Li, Y
Zabora, J
AF BrintzenhofeSzoc, K. M.
Levin, T. T.
Li, Y.
Zabora, J.
TI The prevalence of mixed anxiety-depression by cancer type
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD MAR
PY 2007
VL 16
IS 3
SU Suppl. S
BP S31
EP S32
UT ISI:000245044900057
ER

PT J
AU Doyle, K
Fitzgibbons, L
Rollins, P
Stringer, CA
AF Doyle, K.
Fitzgibbons, L.
Rollins, P.
Stringer, C. A.
TI Changes in depression, anxiety and psychosocial adjustment to illness following an individual intervention for women with advanced stage ovarian cancer
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD MAR
PY 2007
VL 16
IS 3
SU Suppl. S
BP S37
EP S37
UT ISI:000245044900068
ER

PT J
AU West, L
Bauer-Wu, S
Liem, J
Powell, M
AF West, L.
Bauer-Wu, S.
Liem, J.
Powell, M.
TI Factors associated with anxiety and depression in young women recently diagnosed with breast cancer
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD MAR
PY 2007
VL 16
IS 3
SU Suppl. S
BP S92
EP S93
UT ISI:000245044900178
ER

PT J
AU Pandey, M
Sarita, G
Devi, N
Thomas, B
Hussain, BM
Krishnan, R
AF Pandey, M.
Sarita, G.
Devi, N.
Thomas, B.
Hussain, B. M.
Krishnan, R.
TI Distress, anxiety and depression in cancer patients undergoing chemotherapy
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD MAR
PY 2007
VL 16
IS 3
SU Suppl. S
BP S98
EP S98
UT ISI:000245044900189
ER

PT J
AU Pressley, Z
DeLong, L
Curiel-Lewandrowski, C
Chen, S
AF Pressley, Zakiya
DeLong, Laura
Curiel-Lewandrowski, Clara
Chen, Suephy
TI Quality of life and cancer anxiety impact of total body digital photography in patients with atypical mole syndrome
SO JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
SN 0190-9622
PD FEB
PY 2007
VL 56
IS 2
SU Suppl. S
BP AB144
EP AB144
UT ISI:000243972801116
ER

PT J
AU Chauhan, D
Sharpe, L
Clarke, S
Thewes, B
Rickard, J
AF Chauhan, D.
Sharpe, L.
Clarke, S.
Thewes, B.
Rickard, J.
TI Using different screening modalities to assess for anxiety and depression amongst cancer patients
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S105
EP S106
UT ISI:000242413900251
ER

PT J
AU Alvarado, MC
AF Alvarado, M. C.
TI Anxiety in children with cancer and their parents
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S157
EP S157
UT ISI:000242413900370
ER

PT J
AU Grassi, L
Sabato, S
Rossi, E
Marmai, L
Biancosino, B
Gatti, M
AF Grassi, L.
Sabato, S.
Rossi, E.
Marmai, L.
Biancosino, B.
Gatti, M.
TI Depressive and anxiety disorders among cancer patients: Screening methods hy using the distress thermometer compared to the ICD-10
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S162
EP S162
UT ISI:000242413900382
ER

PT J
AU Cankurtaran, ES
Ozalp, E
Soygur, H
Turhan, L
AF Cankurtaran, E. S.
Ozalp, E.
Soygur, H.
Turhan, L.
TI The effect of mirtazapine on depression, anxiety symptoms and quality of life in cancer patients
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S192
EP S193
UT ISI:000242413900452
ER

PT J
AU Ciaramella, A
Lucente, F
Paroli, M
Poli, P
AF Ciaramella, A.
Lucente, F.
Paroli, M.
Poli, P.
TI Differences in pain perception between patients with and without cancer. Role of anxiety and depression
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S200
EP S201
UT ISI:000242413900471
ER

PT J
AU Cousson-Gelie, F
Bruchon-Schweitzer, M
Dilhuydy, JM
Jutand, MA
AF Cousson-Gelie, F.
Bruchon-Schweitzer, M.
Dilhuydy, J. M.
Jutand, M. A.
TI Impact of social support, anxiety and coping on survival after breast cancer: A ten year followup study
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S213
EP S214
UT ISI:000242413900503
ER

PT J
AU Cross, LJ
Clover, KA
Adams, CA
Utram, SC
Ponman, LK
AF Cross, L. J.
Clover, K. A.
Adams, C. A.
Utram, S. C.
Ponman, L. K.
TI A multidisciplinary pilot study to screen for anxiety and distress in cancer patients when a head immobilization device is used for radiotherapy treatment
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S214
EP S214
UT ISI:000242413900504
ER

PT J
AU Geinitz, H
Thamm, R
Keller, M
Molls, M
Zimmermann, F
AF Geinitz, H.
Thamm, R.
Keller, M.
Molls, M.
Zimmermann, F.
TI Longitudinal evaluation of anxiety, depression and quality of life in patients with conformal radiation therapy (CRT) for prostate cancer
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S246
EP S247
UT ISI:000242413901025
ER

PT J
AU Gorayeb, R
Matthes, HTZ
Andrade, JM
AF Gorayeb, R.
Matthes, H. T. Z.
Andrade, J. M.
TI Anxiety, depression and level of knowledge in breast and gynaecological cancer patients in a public University Hospital in Brazil
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S252
EP S253
UT ISI:000242413901039
ER

PT J
AU Lopez Soler, C
Hernandez, S
Fernandez, V
AF Lopez Soler, C.
Hernandez, S.
Fernandez, V
TI Affective and anxiety problems of childhood cancer
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S259
EP S260
UT ISI:000242413901056
ER

PT J
AU Helmes, AW
Vogel, BA
Bengel, J
AF Helmes, A. W.
Vogel, B. A.
Bengel, J.
TI Predictors of anxiety and depression in breast cancer patients: Physician-patient communication or coping?
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S264
EP S265
UT ISI:000242413901067
ER

PT J
AU Hill, KA
Warner, E
Esplen, MJ
Butler, K
Bieenwald, R
AF Hill, K. A.
Warner, E.
Esplen, M. J.
Butler, K.
Bieenwald, R.
TI Distress and breast cancer anxiety among BRCA mutation carriers participating in MRI-based screening
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S267
EP S267
UT ISI:000242413901073
ER

PT J
AU Yamashita, M
Saeki, T
Inoue, S
Mantani, T
Okamura, H
AF Yamashita, M.
Saeki, T.
Inoue, S.
Mantani, T.
Okamura, H.
TI Family functioning as a predictor of depression and anxiety in breast cancer survivors: 3-year prospective study
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S279
EP S279
UT ISI:000242413901101
ER

PT J
AU Lienard, A
Merckaert, I
Libert, Y
Marchal, S
Razavi, D
AF Lienard, A.
Merckaert, I
Libert, Y.
Marchal, S.
Razavi, D.
TI Factors that influence cancer patients' anxiety following a medical consultation. Impact of a communication skills training program for physicians
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S308
EP S308
UT ISI:000242413901169
ER

PT J
AU Mehnert, A
Lehmann, C
Koch, U
Schulte, T
AF Mehnert, A.
Lehmann, C.
Koch, U.
Schulte, T.
TI Presence of prostate cancer related anxiety and psychosocial distress in patients during rehabilitative follow-up care
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S322
EP S322
UT ISI:000242413901201
ER

PT J
AU Neumann, M
Pfaff, H
AF Neumann, M.
Pfaff, H.
TI Sex and empathy of physicians and affection of nurses can improve patients' anxiety level in first months after cancer diagnosis - An explorative, retrospective study in patients with bronchial, oesophagus, colorectal, breast, prostate and skin cancer
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S346
EP S347
UT ISI:000242413901258
ER

PT J
AU Pandey, M
Devi, N
Ramdas, K
Krishnan, R
Thomas, BC
AF Pandey, M.
Devi, N.
Ramdas, K.
Krishnan, R.
Thomas, B. C.
TI Distress, anxiety and depression in patients with head neck cancer undergoing treatment with curative intent
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S359
EP S359
UT ISI:000242413901288
ER

PT J
AU Pikunas, JDKA
Springer, C
AF Pikunas, J. D. K. A.
Springer, C.
TI Anxiety and depression at the point of cancer diagnosis and its relationship to coping
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S369
EP S369
UT ISI:000242413901312
ER

PT J
AU Reis, JC
Lucas, HM
AF Reis, J. C.
Lucas, H. M.
TI Illness representation and levels of quality of life, anxiety and depression in patients with prostate cancer
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S380
EP S380
UT ISI:000242413901339
ER

PT J
AU Schillani, G
Malagoli, M
Tuveri, G
Giraldi, T
AF Schillani, G.
Malagoli, M.
Tuveri, G.
Giraldi, T.
TI Anxiety, depression and mental adaptation in cancer patients - Role of serotonin transporter and monoamine oxidase polymorphism
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S399
EP S399
UT ISI:000242413901384
ER

PT J
AU Snoj, Z
Primic Aakelj, M
Milan, L
AF Snoj, Z.
Primic Aakelj, M.
Milan, L.
TI Depression and anxiety in Slovenian breast cancer patients
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S416
EP S416
UT ISI:000242413901424
ER

PT J
AU Walker, MB
Walker, AA
Walker, LG
Sharp, DM
AF Walker, M. B.
Walker, A. A.
Walker, L. G.
Sharp, D. M.
TI What happens to anxiety and depression in women with early breast cancer accessing an integrated oncology health service?
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD OCT
PY 2006
VL 15
IS 2
SU Suppl. S
BP S452
EP S452
UT ISI:000242413901508
ER

PT J
AU Stephenson, NLN
Swanson, M
Dalton, J
Keefe, FJ
Engelke, M
AF Stephenson, Nancy L. N.
Swanson, Melvin
Dalton, JoAnn
Keefe, Francis J.
Engelke, Martha
TI Partner-delivered reflexology: Effects on cancer pain and anxiety (vol 34, pg 127, 2007)
SO ONCOLOGY NURSING FORUM
SN 0190-535X
PD MAR
PY 2007
VL 34
IS 2
BP 280
EP 280
UT ISI:000244949700012
ER

PT J
AU Frick, E
Tyroller, M
Panzer, M
AF Frick, E.
Tyroller, M.
Panzer, M.
TI Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre
SO EUROPEAN JOURNAL OF CANCER CARE
AB The purpose of the present study is to determine the impact of illness characteristics and psychopathological comorbidity on the quality of life (QoL) of radio-oncological patients in health-related and individual dimensions. Sixty-three of 93 eligible patients (40 women and 23 men) were included in the study during their radiation therapy visit to an outpatient centre annexed to a community hospital in Southern Bavaria, Germany. In a semi-structured interview, we elicited individually relevant life domains rated by the patients according to the 'Schedule for the Evaluation of Individual Quality of Life - Direct Weighting'. In addition, the participants completed the 'European Organization for Research and Treatment of Cancer (EORTC) QoL Questionnaire Core 30' and the 'Hospital Anxiety and Depression Scale'. We also assessed the demand for psychotherapy and utilization of psycho-oncological services. In total, 9.5% of the examined patients suffer from clinically relevant anxiety and/or depression [total Hospital Anxiety and Depression Scale (HADS) score > 19]. There was a weak positive correlation between Karnofsky's Performance Status and QoL. Anxiety and depression were significantly correlated with impaired QoL, especially with impaired individual QoL. There was no association between psychopathological comorbidity and the requirement for psycho-oncological support. Conversely, patients who report difficulties in accepting help had a significantly lower QoL. Psychopathological comorbidity has a considerable influence on QoL of patients undergoing radiotherapy. Measuring the individual QoL appears as an adapted needs assessment and helps the psychotherapist in focusing on the patient's problems and desires. Furthermore, the patient's QoL is a main target in providing or planning mental health care in non-university oncological services.
SN 0961-5423
PD MAR
PY 2007
VL 16
IS 2
BP 130
EP 136
UT ISI:000244942500004
ER

PT J
AU Takahashi, K
Ida, I
Kumano, H
Oshima, A
Yuuki, N
Aihara, M
Sato, H
Majima, T
Yonemura, K
Fukuda, M
Oriuchi, N
Amanuma, M
Endo, K
Matsuda, H
Mikuni, M
AF Takahashi, K.
Ida, I.
Kumano, H.
Oshima, A.
Yuuki, N.
Aihara, M.
Sato, H.
Majima, T.
Yonemura, K.
Fukuda, M.
Oriuchi, N.
Amanuma, M.
Endo, K.
Matsuda, H.
Mikuni, M.
TI Brain metabolic changes associated with the onset of depression and anxiety in cancer patients
SO PSYCHIATRY AND CLINICAL NEUROSCIENCES
SN 1323-1316
PD APR
PY 2007
VL 61
IS 2
BP S7
EP S7
UT ISI:000244600300040
ER

PT J
AU Stephenson, NLN
Swanson, M
Dalton, J
Keefe, FJ
Engelke, M
AF Stephenson, Nancy L. N.
Swanson, Melvin
Dalton, JoAnn
Keefe, Frances J.
Engelke, Martha
TI Partner-delivered reflexology: Effects on cancer pain and anxiety
SO ONCOLOGY NURSING FORUM
AB Purpose/Objectives: To compare the effects of partner-delivered foot reflexology and usual care plus attention on patients' perceived pain and anxiety.
Design: The experimental pretest/post-test design included patient-partner dyads randomly assigned to an experimental or control group.
Setting: Four hospitals in the southeastern United States.
Sample: 42 experimental and 44 control subjects comprised 86 dyads of patients with metastatic cancer and their partners, representing 16 different types of cancer; 23% of patients had lung cancer, followed by breast, colorectal, and head and neck cancer and lymphoma. The subjects had a mean age of 58.3 years, 51% were female, 66% had a high school education or less, and 58% were Caucasian, 40% were African American, and 1% were Filipino.
Methods: The intervention included a 15-to 30-minute teaching session on foot reflexology to the partner by a certified reflexologist, an optional 15-to 30-minute foot reflexology session for the partner, and a 30-minute, partner-delivered foot reflexology intervention for the patient. The control group received a 30-minute reading session from their partners.
Main Research Variables: Pain and anxiety. Findings: Following the initial partner-delivered foot reflexology, patients experienced a significant decrease in pain intensity and anxiety.
Conclusions: A nurse reflexologist taught partners how to perform reflexology on patients with metastatic cancer pain in the hospital, resulting in an immediate decrease in pain intensity and anxiety; minimal changes were seen in the control group, who received usual care plus attention.
Implications for Nursing: Hospitals could have qualified professionals offer reflexology as a complementary therapy and teach interested partners the modality.
SN 0190-535X
PD JAN
PY 2007
VL 34
IS 1
BP 127
EP 132
UT ISI:000243441000022
ER

PT J
AU Schoen, M
Roth, A
Nelson, C
Bhaskaran, V
AF Schoen, Mary
Roth, Andrew
Nelson, Christian
Bhaskaran, Vidhya
TI Anxiety and depression in prostate cancer survivors, postprostatectomy.
SO ONCOLOGY NURSING FORUM
SN 0190-535X
PD JAN
PY 2007
VL 34
IS 1
BP 172
EP 173
UT ISI:000243441000041
ER

PT J
AU Wilson, KG
Chochinov, HM
Skirko, MG
Allard, P
Chary, S
Gagnon, PR
Macmillan, K
De Luca, M
O'Shea, F
Kuhl, D
Fainsinger, RL
Clinch, JJ
AF Wilson, Keith G.
Chochinov, Harvey Max
Skirko, Merika Graham
Allard, Pierre
Chary, Srini
Gagnon, Pierre R.
Macmillan, Karen
De Luca, Marina
O'Shea, Fiona
Kuhl, David
Fainsinger, Robin L.
Clinch, Jennifer J.
TI Depression and anxiety disorders in palliative cancer care
SO JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
AB Depression and anxiety disorders are thought to be common in palliative cancer care, but there is inconsistent evidence regarding their relevance for other aspects of quality of life. In the Canadian National Palliative Care Survey, semi-structured interviews assessing depression and anxiety disorders were administered to 381 patients who were receiving palliative care for cancer. There were 212 women and 169 men, with a median survival of, 63 days. We found that 93 participants (24.4 %, 95 % confidence interval= 20.2-29.0) fulfilled Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition diagnostic criteria for at least one anxiety or depressive disorder (20.7% prevalence of depressive disorders, 13.9% prevalence of anxiety disorders). The most frequent individual diagnosis was major depression (13.1%, 95% confidence interval = 9.9-16.9). Comorbidity was common, with 10.2% of participants meeting criteria for more than one disorder. Those diagnosed with a disorder were significantly younger than other participants (P = 0.002). They also had lower performance status (P = 0.017), smaller social networks (P = 0.008), and less participation in organized religious services (P = 0.007). In addition, they reported more severe distress on 14 of 18 physical symptoms, social concerns, and existential issues. Of those with a disorder, 39.8% were being treated, with antidepressant medication, and 66.7% bad been prescribed a benzodiazepine. In conclusion, it appears that, de/nession, and anxiety disorders are indeed common among patients receiving palliative care. The disorders contribute to a greatly diminished quality of life among people who are dying of cancer.
SN 0885-3924
PD FEB
PY 2007
VL 33
IS 2
BP 118
EP 129
UT ISI:000244268800004
ER

PT J
AU Andrews, A
Rosenbaum, EH
Garlan, R
Siegal, A
Hirschberger, N
Butler, LD
Esserman, L
Spiegel, D
AF Andrews, A.
Rosenbaum, E. H.
Garlan, R.
Siegal, A.
Hirschberger, N.
Butler, L. D.
Esserman, L.
Spiegel, D.
TI The life tape project: a psychosocial intervention for cancer patients and their families to increase communication and support, and reduce isolation and existential anxiety.
SO BREAST CANCER RESEARCH AND TREATMENT
SN 0167-6806
PY 2006
VL 100
SU Suppl. 1
BP S99
EP S99
UT ISI:000242047100287
ER

PT J
AU Wilkinson, SM
Love, SB
Westcombe, AM
Gambles, MA
Burgess, CC
Cargill, A
Young, T
Maher, EJ
Ramirez, AJ
AF Wilkinson, Susie M.
Love, Sharon B.
Westcombe, Alex M.
Gambles, Maureen A.
Burgess, Caroline C.
Cargill, Anna
Young, Teresa
Maher, E. Jane
Ramirez, Amanda J.
TI Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: A multicenter randomized controlled trial
SO JOURNAL OF CLINICAL ONCOLOGY
AB Purpose
To test the effectiveness of supplementing usual supportive care with aromatherapy massage in the management of anxiety and depression in cancer patients through a pragmatic two-arm randomized controlled trial in four United Kingdom cancer centers and a hospice.
Patients and Methods
Two hundred eighty-eight cancer patients, referred to complementary therapy services with clinical anxiety and/or depression, were allocated randomly to a course of aromatherapy massage or usual supportive care alone.
Results
Patients who received aromatherapy massage had no significant improvement in clinical anxiety and/or depression compared with those receiving usual care at 10 weeks postrandomization ( odds ratio [ OR], 1.3; 95% CI, 0.9 to 1.7; P =.1), but did at 6 weeks postrandomization ( OR, 1.4; 95% CI, 1.1 to 1.9; P =.01). Patients receiving aromatherapy massage also described greater improvement in self-reported anxiety at both 6 and 10 weeks postrandomization ( OR, 3.4; 95% CI, 0.2 to 6.7; P =.04 and OR, 3.4; 95% CI, 0.2 to 6.6; P =.04), respectively.
Conclusion
Aromatherapy massage does not appear to confer benefit on cancer patients' anxiety and/or depression in the long-term, but is associated with clinically important benefit up to 2 weeks after the intervention.
SN 0732-183X
PD FEB 10
PY 2007
VL 25
IS 5
BP 532
EP 539
UT ISI:000244176000012
ER

PT J
AU Filipovic, BR
Filipovic, BF
Kerkez, M
Milinic, N
Randelovic, T
AF Filipovic, Branislav R.
Filipovic, Branka F.
Kerkez, Mirko
Milinic, Nikola
Randelovic, Tomislav
TI Depression and anxiety levels in therapy-naive patients with inflammatory bowel disease and cancer of the colon
SO WORLD JOURNAL OF GASTROENTEROLOGY
AB AIM: To assess whether depression and anxiety are more expressed in patients with the first episode of inflammatory bowel disease (IBD) than in individuals with newly discovered cancer of the colon (CCa).
METHODS: A total of 32 patients with IBD including 13 males and 19 females, aged 27 to 74, and 30 patients with CCa including 20 males and 10 females, aged 39-78, underwent a structured interview, which comprised Hamilton's Depression Rating Inventory, Hamilton's Anxiety Rating Inventory and Paykel's Stressful Events Rating Scale.
RESULTS: Patients of the IBD group expressed both depression and anxiety. Depressive mood, sense of guilt, psychomotor retardation and somatic anxiety were also more pronounced in IBD patients. The discriminant function analysis revealed the total depressive score was of high importance for the classification of a newly diagnosed patient into one of the groups.
CONCLUSION: Newly diagnosed patients with IBD have higher levels of depression and anxiety. Moreover, a psychiatrist in the treatment team is advisable from the beginning. (c) 2007 The WJG Press. All rights reserved.
SN 1007-9327
PD JAN 21
PY 2007
VL 13
IS 3
BP 438
EP 443
UT ISI:000243613900017
ER

PT J
AU Bekher, OA
Slonimskaya, EM
Kupriyanova, IE
AF Bekher, O. A.
Slonimskaya, E. M.
Kupriyanova, I. E.
TI Level of anxiety in breast cancer women
SO NEURO-ONCOLOGY
SN 1522-8517
PD OCT
PY 2006
VL 8
IS 4
BP 360
EP 361
UT ISI:000240877300271
ER

PT J
AU Tsutsumi, S
Yamaki, S
Yamaguchi, S
Asao, T
Kuwano, H
AF Tsutsumi, Soichi
Yamaki, Sayaka
Yamaguchi, Satoru
Asao, Takayuki
Kuwano, Hiroyuki
TI Anxiety in outpatients receiving chemotherapy for solid cancer
SO HEPATO-GASTROENTEROLOGY
AB Background/Aims: We conducted this prospective study to assess the anxiety in outpatients receiving chemotherapy for solid cancers.
Methodology: Patients were eligible if they were receiving chemotherapy for solid cancer in an outpatient setting, had a life expectancy of more than 6 months, and were able to complete self-administered questionnaires. The State-Trait Anxiety Inventory (STAI) was used to measure the anxiety levels.
Results: From January to December 2004, 119 patients were recruited, and, of these, 114 completed the questionnaires. Their median age was 60.6 years, and the male-to-female ratio was 1.04:1. Of the 114 patients, 36 had breast cancer, 35, colorectal cancer, 23, gastric cancer, 8, esophageal cancer, 5, non-small-cell cancer, 4, pancreatic cancer, and 3, liver cancer. The state- and trait-anxiety levels were higher for women (p=0.019). Age did not influence the trait-anxiety level, but the state-anxiety levels of younger patients were higher. The periods of chemotherapy raised the state and trait-anxiety levels (p=0.023 and 0.015, respectively). No statistically significant differences were observed according to the type of cancer.
Conclusions: The anxiety levels of outpatients with solid cancer receiving chemotherapy were significantly high. Having access to such information will help oncologists provide appropriate support to their patients.
SN 0172-6390
PD NOV-DEC
PY 2006
VL 53
IS 72
BP 828
EP 830
UT ISI:000242306400005
ER

PT J
AU Dell'Agostino, K
Fiumano, M
Fusco, O
Malugani, F
Berardi, E
Menatti, E
Bartolini, A
AF Dell'Agostino, K.
Fiumano, M.
Fusco, O.
Malugani, F.
Berardi, E.
Menatti, E.
Bartolini, A.
TI Anxiety/depression screening in cancer patient by Zung evaluation form
SO ANNALS OF ONCOLOGY
SN 0923-7534
PY 2006
VL 17
SU Suppl. 11
BP XI34
EP XI34
UT ISI:000242379800128
ER

PT J
AU Seo, PH
Sloane, R
Ingram, SS
Misra, D
Clipp, EC
Montana, GS
Cohen, HJ
AF Seo, P. H.
Sloane, R.
Ingram, S. S.
Misra, D.
Clipp, E. C.
Montana, G. S.
Cohen, H. J.
TI The relationship between older cancer survivors' reports of depression, anxiety and pain to health providers' findings and mortality.
SO JOURNAL OF CLINICAL ONCOLOGY
SN 0732-183X
PD JUN 20
PY 2006
VL 24
IS 18
PN Part 1 Suppl. S
BP 492S
EP 492S
UT ISI:000239009403269
ER

PT J
AU Pasquini, M
Biondi, M
Costantini, A
Cairoli, F
Ferrarese, G
Picardi, A
Sternberg, C
AF Pasquini, M.
Biondi, M.
Costantini, A.
Cairoli, F.
Ferrarese, G.
Picardi, A.
Sternberg, C.
TI Detection and treatment of depressive and anxiety disorders among cancer patients: Feasibility and preliminary findings from a liaison service in an oncology division
SO DEPRESSION AND ANXIETY
AB Our aim in this observational study was to evaluate the feasibility of a multiphasic screening project for the detection and treatment of mood and anxiety disorders among cancer patients in a natural setting. One hundred sixty-five patients with cancer, consecutively admitted to the Oncology Division of San Camillo-Forlanini Hospital, were recruited to the study. All patients had solid tumors; the majority of them were. colon, breast, and lung cancers. All patients completed the Hospital Anxiety and Depression Scale (HADS). Patients screened as positive were administered the following instruments by a psychiatrist. the Structured Clinical Interview for DSM-IV (SCID-I), the Beck Depression Inventory (BDI), the Hamilton Anxiety Rating Scale (HARS), and a validated scale for the rapid dimensional assessment of psychopathology (SVARAD). The BDI, HARS, and SVARAD were administered again at 4 and 10 weeks to all treated patients. Out of 45 patients administered the SCID-I, 37 had a mood or anxiety disorder. Adjustment disorders were identified in 20 patients, depressive disorders in 14, and anxiety disorders in three patients. Most patients were prescribed psychotropic medications: mirtazapine was prescribed to 15 patients, citalopram to 13 patients, and escitalopram to four patients. A significant improvement in symptoms of depression and anxiety was observed on all measures (P <.001). Although the design of the study prevents any firm conclusions about effectiveness, this study suggests that including psychiatric expertise in an oncology division is feasible and may lead to improved detection and treatment of psychiatric disorders among cancer patients. Further randomized trials are needed to elaborate on our findings.
SN 1091-4269
PY 2006
VL 23
IS 7
BP 441
EP 448
UT ISI:000241907600010
ER

PT J
AU Cankurtaran, ES
Soygur, AH
Ozalp, E
Turhan, L
AF Cankurtaran, E. S.
Soygur, A. H.
Ozalp, E.
Turhan, L.
TI Mirtazapine versus tricyclic antidepressants for the treatment of depression, anxiety and distressing symptoms of cancer
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
SN 0924-977X
PD SEP
PY 2006
VL 16
SU Suppl. 4
BP S324
EP S325
UT ISI:000240771301022
ER

PT J
AU Robb, KA
Miles, A
Campbell, J
Evans, P
Wardle, J
AF Robb, Kathryn A.
Miles, Anne
Campbell, John
Evans, Philip
Wardle, Jane
TI Can cancer risk information raise awareness without increasing anxiety? A randomized trial
SO PREVENTIVE MEDICINE
AB Objective. Promoting public awareness of cancer risk factors is an important public health goal, but there is concern that it could heighten anxiety. This study examined the impact of mailed information about colorectal cancer on awareness of risk factors, emotional well-being, and interest in attending screening in a population not previously exposed to screening.
Method. Individuals (3,185) aged 45-66 years registered with general practitioners in South-West England in 2004 were randomized to (1) control group (no information), (2) information on colorectal cancer risk factors, or (3) information on risk factors and colorectal screening. All participants were sent a questionnaire assessing knowledge, anxiety, worry about colorectal cancer, and interest in screening.
Results. Questionnaires (1,945; 61%) were returned. As expected, participants receiving information had significantly greater knowledge than the control group. Anxiety scores were in the normal range and neither anxiety nor worry about cancer differed significantly between the groups. Ninety-three percent of respondents indicated they would be interested in screening, with equally high levels across groups.
Conclusion. This study suggests that information leaflets can promote knowledge of cancer risk factors without increasing anxiety. Low-cost educational materials have the potential to contribute to public engagement with health promotion and disease prevention. (c) 2006 Elsevier Inc. All rights reserved.
SN 0091-7435
PD SEP
PY 2006
VL 43
IS 3
BP 187
EP 190
UT ISI:000240876000007
ER

PT J
AU Antoni, MH
Wimberly, SR
Lechner, SC
Kazi, A
Sifre, T
Urcuyo, KR
Phillips, K
Smith, RG
Petronis, VM
Guellati, S
Wells, KA
Blomberg, B
Carver, CS
AF Antoni, Michael H.
Wimberly, Sarah R.
Lechner, Suzanne C.
Kazi, Aisha
Sifre, Tammy
Urcuyo, Kenya R.
Phillips, Kristin
Smith, Roselyn G.
Petronis, Vida M.
Guellati, Sophie
Wells, Kurrie A.
Blomberg, Bonnie
Carver, Charles S.
TI Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer
SO AMERICAN JOURNAL OF PSYCHIATRY
AB Objective: After surgery for breast cancer, many women experience anxiety relating to the cancer that can adversely affect quality of life and emotional functioning during the year postsurgery. Symptoms such as intrusive thoughts may be ameliorated during this period with a structured, group-based cognitive behavior intervention.
Method: A 10-week group cognitive behavior stress management intervention that included anxiety reduction ( relaxation training), cognitive restructuring, and coping skills training was tested among 199 women newly treated for stage 0-111 breast cancer. They were then followed for 1 year after recruitment.
Results: The intervention reduced reports of thought intrusion, interviewer ratings of anxiety, and emotional distress across 1 year significantly more than was seen with the control condition. The beneficial effects were maintained well past the completion of adjuvant therapy.
Conclusions: Structured, group-based cognitive behavior stress management may ameliorate cancer-related anxiety during active medical treatment for breast cancer and for 1 year following treatment. Group-based cognitive behavior stress management is a clinically useful adjunct to offer to women treated for breast cancer.
SN 0002-953X
PD OCT
PY 2006
VL 163
IS 10
BP 1791
EP 1797
UT ISI:000240906800024
ER

PT J
AU Lienard, A
Merckaert, I
Libert, Y
Delvaux, N
Marchal, S
Boniver, J
Etienne, AM
Klastersky, J
Reynaert, C
Scalliet, P
Slachmuylder, JL
Razavi, D
AF Lienard, A.
Merckaert, I.
Libert, Y.
Delvaux, N.
Marchal, S.
Boniver, J.
Etienne, A. -M.
Klastersky, J.
Reynaert, C.
Scalliet, P.
Slachmuylder, J. -L.
Razavi, D.
TI Factors that influence cancer patients' anxiety following a medical consultation: impact of a communication skills training programme for physicians
SO ANNALS OF ONCOLOGY
AB Background: No study has yet assessed the impact of physicians' skills acquisition after a communication skills training programme on the evolution of patients' anxiety following a medical consultation. This study aimed to compare the impact, on patients' anxiety, of a basic communication skills training programme (BT) and the same programme consolidated by consolidation workshops (CW), and to investigate physicians' communication variables associated with patients' anxiety.
Patients and methods: Physicians, after attending the BT, were randomly assigned to CW or to a waiting list. The control group was not a non-intervention group. Consultations with a cancer patient were recorded. Patients' anxiety was assessed with the State Trait Anxiety Inventory before and after a consultation. Communication skills were analysed according to the Cancer Research Campaign Workshop Evaluation Manual.
Results: No statistically significant change over time and between groups was observed. Mixed-effects modelling showed that a decrease in patients' anxiety was linked with screening questions (P = 0.045), physicians' satisfaction about support given (P = 0.004) and with patients' distress (P < 0.001). An increase in anxiety was linked with breaking bad news (P = 0.050) and with supportive skills (P = 0.013). No impact of the training programme was observed.
Conclusions: This study shows the influence of some communication skills on the evolution of patients' anxiety. Physicians should be aware of these influences.
SN 0923-7534
PD SEP
PY 2006
VL 17
IS 9
BP 1450
EP 1458
UT ISI:000240587900017
ER

PT J
AU Osborn, RL
Demoncada, AC
Feuerstein, M
AF Osborn, Robyn L.
Demoncada, Angelique C.
Feuerstein, Michael
TI Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: Meta-analyses
SO INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE
AB Objective: The purpose of this meta-analysis was to investigate the effects of cognitive behavioral therapy (CBT) and patient education (PE) on commonly reported problems (depression, anxiety, pain, physical functioning, and quality of life (QOL)) in adult cancer survivors. Methods: Meta analyses of randomized controlled trials of CBT and PE were conducted. MEDLINE, PSYCHINFO and the Cochrane Database were searched from 1993-2004. The effects of individual versus group interventions and short (< 8 months) versus long (> 8 months) term follow up are also reported. Results: Fifteen studies met quality criteria. The sample size was 1,492 adult cancer survivors with an age range of 18-84. 790 were randomly assigned to intervention groups and 702 to control groups. CBT varied in duration from 4 weekly one-hour sessions to 55 weekly two-hour sessions. PE ranged from a single 20-minute session to 6 weekly one-hour sessions. Follow up ranged from I week to 14 months. CBT was effective for depression (ES = 1.2; 95% Cl = 0.22-2.19), anxiety (ES = 1.99; 95% Cl = 0.69-3.31), and QOL (ES = 0.91; 95% CI = 0.38-1.44). QOL was improved at both short and (ES = 1.45, 95% CI =.43-2.47) and long term (ES =.26; 95% Cl =.06-.46) follow up. PE was not related to improved outcomes. Conclusions: CBT is related to short-term effects on depression and anxiety and both short and long term effects on QOL. Individual interventions were more effective than group. Various CBT approaches provided in an individual format can assist cancer survivors in reducing emotional distress and improving quality of life.
SN 0091-2174
PY 2006
VL 36
IS 1
BP 13
EP 34
UT ISI:000239498300002
ER

PT J
AU Kahan, Z
Varga, K
Dudas, R
Nyari, T
Thurzo, L
AF Kahan, Zsuzsanna
Varga, Katalin
Dudas, Rita
Nyari, Tibor
Thurzo, Laszlo
TI Collaborative/active participation per se does not decrease anxiety in breast cancer
SO PATHOLOGY & ONCOLOGY RESEARCH
AB The information needs of breast cancer patients on their disease, its treatment, the prognosis, and their attitude to decision-making concerning treatment were assessed. One hundred and fifty early and 45 metastatic breast cancer patients were recruited into the study. The amount of information and role in the treatment decision-making process preferred by the patient were independently estimated by the patient and the oncologist, using questionnaires. Information was provided in accordance with the wishes of the patient as perceived by the physician. Test of anxiety was performed before, and one week after the consultation. Most of the patients claimed to anticipate the provision of extensive information and an active role in the decision-making, but real interest during the consultation was found less frequently. The post-consultation anxiety test revealed a significant decrease in situational anxiety; this was not related to the patient's information needs or her attitude to the decision-making concerning treatment. Our study demonstrates that a significant decrease in anxiety may be achieved via a consultation tailored to the needs of the patient. Loading the patient with information and involvement in the decision regarding therapy as much as the patient seems comfortable with lowers distress.
SN 1219-4956
PY 2006
VL 12
IS 2
BP 93
EP 101
UT ISI:000239140500006
ER

PT J
AU Rogers, SN
Rajlawat, B
Goru, J
Lowe, D
Humphris, GM
AF Rogers, Simon N.
Rajlawat, Bijaya
Goru, Janaki
Lowe, Derek
Humphris, Gerry M.
TI Comparison of the domains of anxiety and mood of the University of Washington Head and Neck Cancer Questionnaire (UW-QOL v4) with the CES-D and HADS
SO HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
AB Background. Version 4 of the University of Washington Head and Neck Cancer Questionnaire (UW-QOLv4) includes items on mood and anxiety. The aim of this study was to compare the responses to these single items with the Centre for Epidemiology Studies Depression Scale (CES-D) and the Hospital Anxiety Depression Scale (HADS).
Methods. A cross-sectional postal survey was undertaken in April 2003. The survey was composed of all patients treated for oral and oropharyngeal squamous cell carcinoma between 1992 and 2002 who were alive and disease free.
Results. We distributed 306 questionnaires; there were 197 replies (65%) from 110 male and 87 female patients. Most patients reported relatively little depression, with 170 of 190 (89%) reporting a HADS depression score of less than 11. Similarly, most patients were not anxious, with 158 of 183 (86%) reporting a HADS anxiety score of less than 11. UW-QOL mood, UW-QOL anxiety, HADS anxiety, HADS depression, and CES-D scores were all moderately intercorrelated (Spearman correlations from 0.39-0.68 ignoring the signs, all p < .001). The UW-COIL mood correlated with the scores and "case-ness" categories of the HADS depression and CES-D scales, whereas the UW-QOL anxiety correlated with the scores and "case-ness" of the HADS anxiety.
Conclusions. Questions on mood and anxiety can help identify significant psychological 'morbidity, taking a score of less than 75 for UW-QOL mood and less than 70 for UW-OOL anxiety. This could be used to trigger formal psychological assessment and with a view to possible therapeutic intervention. (c) 2006 Wiley Periodicals, Inc.
SN 1043-3074
PD AUG
PY 2006
VL 28
IS 8
BP 697
EP 704
UT ISI:000239179900005
ER

PT J
AU Roth, A
Nelson, CJ
Rosenfeld, B
Warshowski, A
O'Shea, N
Scher, H
Holland, JC
Slovin, S
Curley-Smart, T
Reynolds, T
Breitbart, W
TI Assessing anxiety in men with prostate cancer: Further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC)
SO PSYCHOSOMATICS
AB Identifying which men with prostate cancer might benefit from mental health treatment has proven to be a challenging task. The authors developed the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in order to facilitate the identification of prostate cancer-related anxiety. A revised version of this scale was tested in a more clinically varied population. Ambulatory men with prostate cancer (N = 367) completed a baseline assessment packet that included the MAXPC and other psychosocial questionnaires. The MAX-PC showed high internal consistency and concurrent and discriminant validity. Factor analysis identified three distinct factors for the MAX-PC that corresponded to the intended subscales (General Prostate Cancer Anxiety, PSA (prostate-specific antigen) Anxiety, and Fear of Recurrence). PSA levels were not correlated with anxiety overall; however, anxiety was significantly higher among patients whose PSA levels were changing (i.e., rising, falling, and unstable), versus those with stable PSA levels. Also, in a multivariate analysis, the change in PSA levels was a significant predictor of MAX-PC scores, but not Hospital Anxiety and Depression Scale (HADS) scores. These results indicate that the MAX-PC is a valid and reliable measure of anxiety that assesses aspects of anxiety unique to men with prostate cancer and it may provide a more sensitive measure of anxiety than the HADS for this population.
SN 0033-3182
PD JUL-AUG
PY 2006
VL 47
IS 4
BP 340
EP 347
UT ISI:000238767900011
ER

PT J
AU Tagay, S
Herpertz, S
Langkafel, M
Erim, Y
Bockisch, A
Senf, W
Gorges, R
TI Health-related quality of life, depression and anxiety in thyroid cancer patients
SO QUALITY OF LIFE RESEARCH
AB Objectives: We examined the relationships among physical complaints, health-related quality of life (HRQL), anxiety and depression in differentiated thyroid cancer (DTC) patients under short-term hypothyroidism.
Methods: We conducted a cross-sectional study in 136 patients hypothyroid on thyroid hormone withdrawal (THW) hospitalized for radioiodine administration. Patients were assessed using Short Form SF-36 (SF-36), Hospital Anxiety and Depression Scale (HADS), Profile of Mood States (POMS), Beck Depression Inventory (BDI), and physical complaints.
Results: Compared to the German general population, hypothyroid patients had significantly impaired HRQL. Surprisingly, the prevalence of anxiety (62.5%), but not depression (17.9%) was much higher in hypothyroid DTC patients than in the general population. In multivariate analysis, depression and age were independently associated with the physical health score (R-2 = 0.21), but only psychological variables (depression, mood disturbance, and anxiety) were associated with the mental health score (R-2 = 0.43), on the SF-36 HRQL instrument.
Conclusions: HRQL is severely impaired in DTC patients under short-term hypothyroidism. As potential predictors of generic HRQL impairment, depression, anxiety, and mood disturbance could be used to preselect the patients most needing psychiatric care. The high frequency of anxiety should be considered in the aftercare of thyroid cancer patients.
SN 0962-9343
PD MAY
PY 2006
VL 15
IS 4
BP 695
EP 703
UT ISI:000237489100012
ER

PT J
AU Hedstrom, M
Kreuger, A
Ljungman, G
Nygren, P
von Essen, L
TI Accuracy of assessment of distress, anxiety, and depression by physicians and nurses in adolescents recently diagnosed with cancer
SO PEDIATRIC BLOOD & CANCER
AB Background. As staff members prioritize medical resources for patients, it is imperative to find Out whether their assessments of patients' health status agree with patients' assessments. The degree to which physicians and nurses can identify the distress, anxiety, and depression experienced by adolescents recently diagnosed with cancer was examined here. Procedure. Adolescents undergoing chemotherapy (13-19 years, n = 53), physicians (n 48), and nurses (n=53) completed a structured telephone interview, 4-8 weeks after diagnosis or relapse, investigating disease and treatment-related distress, anxiety, and depression. Results. The accuracy of staff ratings of physical distress could be considered acceptable. However, problems of a psychosocial nature, which were frequently overestimated, were difficult for staff to identify. Staff underestimated the distress caused by mucositis and worry about missing school more than they overestimated distress. These aspects were some of the most prevalent and overall worst according to the adolescents. Both physicians and nurses overestimated levels of anxiety and depression. Nurses tended to show higher sensitivity than physicians for distress related to psychosocial aspects of distress, while physicians tended to show higher accuracy than nurses for physical distress. Conclusions. Staff was reasonably accurate at identifying physical distress in adolescents recently diagnosed with cancer whereas psychosocial problems were generally poorly identified. Thus, the use of staff ratings as a "test" to guide specific Support seems problematic. Considering that the accuracy of staff ratings outside a research study is probably lower, identification of and action taken on adolescent problems in relation to cancer diagnosis and treatment need to rely on direct communication.
SN 1545-5009
PD JUN
PY 2006
VL 46
IS 7
BP 773
EP 779
UT ISI:000237304100013
ER

PT J
AU Norberg, AL
Lindblad, F
Boman, KK
TI Support-seeking, perceived support, and anxiety in mothers and fathers after children's cancer treatment
SO PSYCHO-ONCOLOGY
AB The objective was to examine the relationships between anxiety, the seeking of social support as a coping strategy, and perceived social support among mothers (n = 103) and fathers (n = 8 1) of children with successfully completed treatment for cancer. Assessments were done using self-report instruments. The mediating effect of perceived support on the relationship between social support-seeking and anxiety was evaluated through path analysis, and comparisons were done in order to evaluate effects of gender.
For mothers and fathers alike, a positive relationship of moderate strength between support-seeking and perceived support was found. Anxiety was negatively related to support-seeking (mothers r = -0.22, p = 0.025; fathers r = -0.21, p = 0.063) as well as perceived support (mothers r = -0.55, p < 0.001; fathers r = -0.41 p < 0.001), although the relationship for support-seeking was weak. The path analysis showed that perceived support only to a minor extent could strengthen this association. The significance of support-seeking and perceived support was stronger for mothers than for fathers, as regards their association with anxiety. However, the patterns of interrelations were similar for mothers and fathers. In conclusion, parents' subjectively perceived support appears to be more important for anxiety regulation than their support-seeking coping. In clinical practice, individual variation should be acknowledged, and presumptions of general gender differences avoided. Copyright (c) 2005 John Wiley & Sons, Ltd.
SN 1057-9249
PD APR
PY 2006
VL 15
IS 4
BP 335
EP 343
UT ISI:000236993400006
ER

PT J
AU Jones, RB
Pearson, J
Cawsey, AJ
Bental, D
Barrett, A
White, J
White, CA
Gilmour, WH
TI Effect of different forms of information produced for cancer patients on their use of the information, social support, and anxiety: randomised trial
SO BRITISH MEDICAL JOURNAL
AB Objective To explore the hypothesis that different methods of selecting and printing information for cancer patients could improve emotional support by affecting interaction with others, and so lead to improved psychological wellbeing.
Design Randomised trial with eight groups (three factors, 2x2x2). Data collected at recruitment and three month follow-up.
Participants 400 patients starting radiotherapy, Of whom 325 with breast or prostate cancer and complete anxiety and depression data were included in the analysis.
Interventions Printed booklets: half had only general information from CancerBACUP about each patients cancer and half had personalised information from the patient's medical record plus selected general information; half were composed of information chosen interactively by the patient and half were produced automatically with a larger volume of material; mid half had additional advice on anxiety management.
Main outcome measures Patients' views of the information, use of their booklets with others; change in reported social support; change in anxiety and depression.
Results The larger booklets produced automatically were more likely to be found useful and to tell patients something new and less likely to be seen as too limited than the booklets produced interactively, but they were also more likely to overwhelm some patients. Personalised booklets were more likely than general booklets to tell patients something new. There was no difference in patients' perceived understanding of their cancer by any of the intervention factors. Patients with personalised information were more likely to show their booklets to others and to think it helped in discussing their, cancer or its treatment. There were no major differences in social support, anxiety, or depression by an), intervention factors.
Conclusions Patients were more likely to show personalised information to their confidants than general information. Further research is needed into the effects of sharing information on patients' social Support and anxiety.
SN 0959-8146
PD APR 22
PY 2006
VL 332
IS 7547
BP 942
EP 946A
UT ISI:000237143900016
ER

PT J
AU McCoubrie, R
Davies, A
TI Is there a correlation between spirituality and anxiety and depression in patients with advanced cancer?
SO SUPPORTIVE CARE IN CANCER
AB Aims and objectives: To establish whether there is a correlation between spirituality and anxiety and depression in patients with advanced cancer. Patients and methods: Patients with a diagnosis of cancer at St. Peter's day hospice in Bristol were asked to complete three questionnaires to assess anxiety, depression and spirituality. Informed consent was obtained. Anxiety and depression are indicated by the Hospital Anxiety and Depression Scale score, and spirituality is indicated by scores on the Spiritual Well-Being Scale (SWBS) and the Royal Free Interview for Spiritual and Religious Beliefs. As will be explained, religion and spirituality are generally recognised as having different meanings-religion entailing a relationship with a higher being, while spirituality can be thought of in terms of meaning and purpose in life. Results: Eighty-five complete data sets were obtained. A significant negative correlation was found between both anxiety and depression scores and overall spiritual well-being scores (p < 0.0001). When the SWBS subscale scores were analysed individually, a significant negative correlation was found between the existential well-being scores and the anxiety and depression scores (p < 0.001). However, no correlation was found between the religious well-being scores and anxiety or depression. Conclusions: This study found a significant negative correlation between spirituality (in particular, the existential aspect) and anxiety and depression in patients with advanced cancer. Religious well-being and strength of belief had no impact on psychological well-being in this study.
SN 0941-4355
PD APR
PY 2006
VL 14
IS 4
BP 379
EP 385
UT ISI:000236983200012
ER

PT J
AU Korfage, IJ
Esskink-Bot, ML
Janssens, ACJW
Schroder, FH
de Koning, HJ
TI Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up
SO BRITISH JOURNAL OF CANCER
AB To document anxiety and depression from pretreatment till 5-year follow-up in 299 men with localized prostate cancer. To assess, if baseline scores were predictive for anxiety and depression at 1-year follow-up. Respondents completed four assessments (pretreatment, at 6 and 12 months, and at 5-year follow-up) on anxiety, depression and mental health. Respondents were subdivided according to therapy (prostatectomy or radiotherapy) and high vs low-anxiety. Pretreatment 28% of all patients were classified as 'high-anxiety'; their average anxiety scores decreased significantly post-treatment, that is towards less anxiety. At all assessments, high-anxiety men treated by prostatectomy reported less depression than high-anxiety men treated by radiotherapy. Of men treated by radiotherapy, 27% reported clinical significant levels of depression while 20% is expected in a general population. The improvement in mental health at 6-months follow-up was statistically significant and clinically meaningful in all respondent groups. Sensitivity of anxiety at baseline as a screening tool was 71% for anxiety and 60% for symptoms of depression. We recommend clinicians to attempt early detection of patients at risk of high levels of anxiety and depression after prostate cancer diagnosis since prevalence is high. STAI-State can be a useful screening tool but needs further development.
SN 0007-0920
PD APR 24
PY 2006
VL 94
IS 8
BP 1093
EP 1098
UT ISI:000236910300002
ER

PT J
AU Rimes, KA
Salkovskis, PA
Jones, L
Lucassen, AA
TI Applying a cognitive-behavioral model of health anxiety in a cancer genetics service
SO HEALTH PSYCHOLOGY
AB A cognitive-behavioral model of health anxiety was used to investigate reactions to genetic counseling for cancer. Participants (N = 218) were asked to complete a questionnaire beforehand and 6 months later. There was an overall decrease in levels of cancer-related anxiety, although 24% of participants showed increased cancer-related anxiety at follow-up. People who had a general tendency to worry about their health reported more cancer-related anxiety than those who did not at both time points. This health-anxious group also showed a postcounseling anxiety reduction, whereas the others showed no significant change. Participants with breast or ovarian cancer in their family were more anxious than participants with colon cancer in their family. Preexisting beliefs were significant predictors of anxiety, consistent with a cognitive-behavioral approach.
SN 0278-6133
PD MAR
PY 2006
VL 25
IS 2
BP 171
EP 180
UT ISI:000236681200005
ER

PT J
AU Saevarsdottir, T
Fridriksdottir, N
Gunnarsdottir, S
TI Quality of life, symptoms of anxiety and depression, and rehabilitation needs of people receiving chemotherapy for cancer at the initiation of chemotherapy and three months later.
SO ONCOLOGY NURSING FORUM
SN 0190-535X
PD MAR
PY 2006
VL 33
IS 2
BP 469
EP 469
UT ISI:000236697600285
ER

PT J
AU [Anon]
TI Trait anxiety predicts fatigue in women with early stage breast cancer
SO EJC SUPPLEMENTS
SN 1359-6349
PD MAR
PY 2006
VL 4
IS 2
BP 91
EP 92
UT ISI:000236447700183
ER

PT J
AU Mehnert, A
Cao, P
Graefen, M
Huland, H
Koch, U
TI Prevalence of post-traumatic stress disorder, anxiety and depression in patients with prostate cancer
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD FEB
PY 2006
VL 15
IS 1
SU Suppl. S
BP S66
EP S66
UT ISI:000235659000125
ER

PT J
AU Greer, JA
Zhang, BH
Vanderwerker, LC
Prigerson, HG
TI Prevalence and correlates of anxiety in patients with advanced cancer
SO PSYCHO-ONCOLOGY
SN 1057-9249
PD FEB
PY 2006
VL 15
IS 1
SU Suppl. S
BP S81
EP S82
UT ISI:000235659000152
ER

PT J
AU Thomas, BC
Devi, N
Sarita, GP
Rita, K
Ramdas, K
Hussain, BM
Rejnish, R
Pandey, M
TI Reliability & validity of the Malayalam hospital anxiety & depression scale (HADS) in cancer patients
SO INDIAN JOURNAL OF MEDICAL RESEARCH
AB Background & objectives: The hospital anxiety and depression scale (HADS) has been widely used on cancer patients as an indicator of psychological morbidity. Though the scale has been used in India, no reports are available on translation of HADS in any Indian language and testing the reliability. The present study describes the translation process of HADS into Malayalam and testing its reliability and validity on psychological morbidity in cancer patients.
Methods: The English version of the HADS was translated into Malayalam and was used in this study. The questionnaire was administered to 240 cancer patients and statistical analysis was carried out using Chronbach's alpha to test the internal consistancy of the HADS scale while confirmatory factor analysis was carried out using principal axis factoring with equimax rotation and Kaiser Normalization to test its construct validity.
Results: The Cronbach's alpha was found to be 0.81 for the HADS anxiety subscale, 0.71 for the BADS depression subscale, and 0.85 for RADS tool. Confirmatory factor analysis (CFA) indicated two depression items (i.e., enjoyment and anhedonia) loading onto the anxiety subscale. Clinical caseness for anxiety was observed in 8 per cent, while 11 per cent of the patients had borderline mood disorder. Clinical caseness for depression was identified in 7.6 and 13 per cent of patients were found to have borderline mood disturbances.
Interpretation & conclusion: This preliminary validation study of the Malayalam version of the HADS showed it as an acceptable, and reliable measure of psychological morbidity among cancer patients. The prevalence of anxiety and depression in Indian population was low and enjoyment and anhedonia might present as anxiety initially.
SN 0971-5916
PD NOV
PY 2005
VL 122
IS 5
BP 395
EP 399
UT ISI:000235017900007
ER

PT J
AU Tagay, S
Herpertz, S
Langkafel, M
Erim, Y
Freudenberg, L
Schopper, N
Bockisch, A
Senf, W
Gorges, R
TI Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
AB Objective: Very few previous studies have compared the degree of health-related quality of life (HRQL), depression and anxiety of differentiated thyroid cancer patients (DTC) under short-term hypothyroidism and levothyroxine treatment.
Methods: Using patient-completed instruments, we examined the frequency of physical complaints, HRQL, anxiety and depression in 130 DTC patients hospitalized for radioiodine therapy or whole-body diagnostics (age 52 years, female 71%) under short-term hypothyroidism (4 weeks of levothyroxine withdrawal; DTC-H) and in 100 DTC out-patients under TSH-suppressive doses of levothyroxine subsequent to radioiodine therapy (DTC-L; age 49 years, female 81%).
Results: Compared with the German general population, DTC-H as well as DTC-L patients had significantly impaired HRQL. Notably, the decrease in HRQL was significantly higher in DTC-H than in DTC-L patients. Surprisingly, the prevalence of anxiety (44.6%) but not depression (17.7%) was much higher in the DTC-H patients than in the general population. In contrast to expectations, similar results for anxiety (44.0%) and depression (17.6%) were observed in the DTC-L patients.
Conclusions: This mounting evidence suggests that a consistent pattern of HRQL impairment is experienced by patients with DTC. The high frequency of anxiety and the significantly reduced HRQL should be considered in the aftercare of DTC patients.
SN 0804-4643
PD DEC
PY 2005
VL 153
IS 6
BP 755
EP 763
UT ISI:000234216100005
ER

PT J
AU Gothelf, D
Rubinstein, M
Shemesh, E
Miller, O
Farbstein, I
Klein, A
Weizman, A
Apter, A
Yaniv, I
TI Pilot study: Fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer
SO JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
AB Objective: To evaluate the safety, tolerability, and benefit of fluvoxamine for the treatment of major depressive disorder or anxiety disorders in children and adolescents with cancer. Method: The study was conducted from 2001 to 2004 at a pediatric hematology-oncology center. Fifteen children and adolescents with cancer were treated with fluvoxamine 100 mg/day in an open prospective 8-week trial. Safety and tolerability were evaluated at baseline and at weeks 4 and 8 by blood tests and the Side Effects Checklist. Clinical benefit was assessed with the Clinical Global ImpressionsImprovement, the Children's Depression Rating Scale-Revised, and the Pediatric Anxiety Rating Scale. Results: Fluvoxamine was well tolerated by all subjects. Psychiatric symptoms improved significantly. Conclusions: In this open trial, fluvoxamine appeared to be well tolerated and was associated with a promising reduction in the depression and anxiety symptoms of pediatric patients with cancer.
SN 0890-8567
PD DEC
PY 2005
VL 44
IS 12
BP 1258
EP 1262
UT ISI:000233470000007
ER

PT J
AU Bez, Y
Topcuoglu, V
Kemal, KM
Demir, A
Turkeri, L
TI Comparison of depression, anxiety and quality of life in prostate cancer patients with and without sexual dysfunctions
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
SN 0022-3999
PD JUL
PY 2005
VL 59
IS 1
BP 23
EP 24
UT ISI:000232433800011
ER

PT J
AU Ozkan, M
Kurt, A
TI The comparison of anxiety and depression in patients with cancer pain and non-cancer chronic pain
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
SN 0022-3999
PD JUL
PY 2005
VL 59
IS 1
BP 42
EP 42
UT ISI:000232433800084
ER

PT J
AU Ozkan, S
Sipahi, B
TI Evaluation of anxiety, depression expressive motions of mothers with children who has cancer from a psychosocial perspective
SO JOURNAL OF PSYCHOSOMATIC RESEARCH
SN 0022-3999
PD JUL
PY 2005
VL 59
IS 1
BP 43
EP 43
UT ISI:000232433800086
ER

PT J
AU Monti, DA
Mago, R
Kunkel, EJS
TI Depression, cognition, and anxiety among postmenopausal women with breast cancer
SO PSYCHIATRIC SERVICES
SN 1075-2730
PD NOV
PY 2005
VL 56
IS 11
BP 1353
EP 1355
UT ISI:000233118200004
ER

PT J
AU Asanami, C
Tei, K
Totsuka, Y
Katakura, A
Shibahara, T
Ueda, M
Yamashita, T
N